Uterine Inflammatory Myofibroblastic Tumors: p16 as a Surrogate for CDKN2A Deletion and Predictor of Aggressive Behavior.

Devins, Kyle M; Ordulu, Zehra; Mendoza, Rachelle P; Croce, Sabrina; Haridas, Rishikesh; Wanjari, Pankhuri; Pinto, Andre; Oliva, Esther; Bennett, Jennifer A

Devins, Kyle M; Ordulu, Zehra; Mendoza, Rachelle P; Croce, Sabrina; Haridas, Rishikesh; Wanjari, Pankhuri; Pinto, Andre; Oliva, Esther; Bennett, Jennifer A.

Affiliation

Devins KM; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Ordulu Z; Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL.
Mendoza RP; Department of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY.
Croce S; Department of Biopathology, Institut Bergonie, Bordeaux, France.
Haridas R; Department of Pathology, University of Chicago, Chicago, IL.
Wanjari P; Department of Pathology, University of Chicago, Chicago, IL.
Pinto A; Department of Pathology, University of Miami, Miami, FL.
Oliva E; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Bennett JA; Department of Pathology, University of Chicago, Chicago, IL.

Am J Surg Pathol ; 48(7): 813-824, 2024 Jul 01.

Article de En | MEDLINE | ID: mdl-38630911

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'utérus / Marqueurs biologiques tumoraux / Inhibiteur p16 de kinase cycline-dépendante Limites: Adolescent / Adult / Aged / Child / Female / Humans / Middle aged Langue: En Journal: Am J Surg Pathol Année: 2024 Type de document: Article Pays d'affiliation: Maroc Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google